Market Research Logo

US Market Report for Erectile Dysfunction Devices 2016 - MedCore

US Market Report for Erectile Dysfunction Devices 2016 - MedCore

For an erection to occur, blood flows into the penis, causing it to expand and stiffen, which is sparked by impulses from the brain to the genital nerves. ED can be caused when these impulses are blocked or the flow of blood to the penis is restricted. Chronic diseases such as diabetes, cardiovascular disease, atherosclerosis, kidney disease and multiple sclerosis can be common underlying causes. Certain medications, psychological factors and injuries could also be factors leading to ED.

Treatments for ED include medications, lifestyle changes, injections, surgeries and devices. Common medications prescribed for ED include sildenafil (Viagra®), tadalafil (Cialis®), vardenafil hydrochloride (Levitra®) and avanafil (StendraTM), which are taken orally prior to intercourse. This group of medications, called phosphodiesterase type 5 (PDE-5) inhibitors, increase the flow of blood to the penis. It can be dangerous for men to take PDE-5 concurrently with nitrate drugs for heart disease or alpha-blockers for benign prostate hyperplasia (BPH). There is a 50% success rate using drug therapy; the remaining 50% of unsuccessful patients may opt to get vasodilators injected into the penis. Other options for when drug therapy options fail include the use of a vacuum device or penile implant surgeries. While the condition is quite common, only approximately 20% of men who experience ED will seek treatment.

ED implantation procedures are performed in outpatient offices and are completed in 1 or 2 hours. Vacuum constriction devices are external devices that use a constriction band or ring to help maintain an erection. They can be preferred over implantation procedures as they are non-invasive.Erectile dysfunction (ED) can be described as the frequent inability for a man to attain and sustain an erection; this could inhibit sexual intercourse and affect quality of life. Onset of ED can begin at the age of 40 and affects 18 to 30 million men. Occasional failure to achieve an erection is not uncommon but a prevalence of 50% or more of the time could be an indication that treatment is required. ED tends to increase with age but treatment can be sought at any age.


EXECUTIVE SUMMARY
1.1 U.S. UROLOGICAL DEVICE MARKET OVERVIEW
1.2 COMPETITIVE ANALYSIS
1.3 MARKET TRENDS
1.4 MARKETS INCLUDED
1.5 PROCEDURE NUMBERS
1.6 PROCEDURE CODES INVESTIGATED
1.7 MARKET DEVELOPMENTS
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
ERECTILE DYSFUNCTION DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Low Testosterone Pharmaceutical Delivery
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Inflatable Erectile Dysfunction Device Market
3.3.2 Malleable Erectile Dysfunction Device Market
3.3.3 Vacuum Erection Device Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
LIDT OF CHART
Chart 1 1: Urological Device Market by Segment, U.S., 2012 – 2022
Chart 1 2: Urological Device Market Overview, 2015 and 2022
Chart 3 1: Erectile Dysfunction Device Market by Type, U.S., 2012 – 2022
Chart 3 2: Erectile Dysfunction Device Market Breakdown, U.S., 2015
Chart 3 3: Erectile Dysfunction Device Market Breakdown, U.S., 2022
Chart 3 4: Inflatable Erectile Dysfunction Device Market, U.S., 2012 – 2022
Chart 3 5: Malleable Erectile Dysfunction Market, U.S., 2012 – 2022
Chart 3 6: Vacuum Erection Device Market, U.S., 2012 – 2022
Chart 3 7: Leading Competitors, Erectile Dysfunction Device Market, U.S., 2015
LIST OF FIGURES
Figure 1 1: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 1 2: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2015
Figure 1 4: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Urological Markets Covered, U.S., 2015 (1 of 5)
Figure 1 7: Urological Markets Covered, U.S., 2015 (2 of 5)
Figure 1 8: Urological Markets Covered, U.S., 2015 (3 of 5)
Figure 1 9: Urological Markets Covered, U.S., 2015 (4 of 5)
Figure 1 10: Urological Markets Covered, U.S., 2015 (5 of 5)
Figure 1 11: Urological Procedures Covered, U.S., 2015 (1 of 2)
Figure 1 12: Urological Procedures Covered, U.S., 2015 (2 of 2)
Figure 1 13: Procedural Codes Investigated, U.S., 2015
Figure 1 14: Recent Events in the Urological Device Market, U.S., 2012 - 2015
Figure 1 15: Key Report Updates
Figure 1 16: Version History
Figure 3 1: Erectile Dysfunction Device Market by Type, U.S., 2012 – 2022 (US$M)
Figure 3 2: Inflatable Erectile Dysfunction Device Market, U.S., 2012 – 2022
Figure 3 3: Malleable Erectile Dysfunction Device Market, U.S., 2012 – 2022
Figure 3 4: Vacuum Erection Device Market, U.S., 2012 – 2022
Figure 3 5: Drivers and Limiters, Erectile Dysfunction Device Market, U.S., 2015
Figure 3 6: Leading Competitors, Erectile Dysfunction Device Market, U.S., 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report